Online registrations are processed securely and confirmed immediately by email. Below you will find information related to registration fees, special rate categories, registration changes, and ...

View detailed information below on submitting an abstract including submission categories, guidelines, and policies.

Voting in this year’s ASCO Election closed on Monday, December 8, 2025, at 3:00 PM Eastern Standard Time, USA. Election results will be announced mid-December and newly elected leaders will begin ...

Federal funding propels cancer research forward — it fuels breakthroughs, drives progress, and brings us closer to conquering cancer. Federal research is on the chopping block for Fiscal Year (FY) ...

All Conquer Cancer research grant applications are carefully reviewed and evaluated by an independent Grants Selection Committee (Committee) using consistent criteria across all applications for each ...

Robin T. Zon, Erin B. Kennedy, Kerin Adelson, Sibel Blau, Natalie Dickson, David Gill, Nicole Laferriere, Ana Maria Lopez, Therese M. Mulvey, Debra Patt, Todd A ...

ASCO stands with our Ukrainian members, the worldwide oncology community, and health care providers around the globe in condemning Russia’s unprovoked war on Ukraine. We call for an immediate ...

American Society of Clinical Oncology, Inc. (“ASCO”) permits text links to any of the pages or content on ASCO’s family of websites, in accordance with the terms and conditions set forth in this ...

The American Society of Clinical Oncology (ASCO) today released a position statement on state drug repository programs, outlining ASCO’s support for drug repository programs solely for oral ...

The following is a message from the Director of the FDA Oncology Center of Excellence, Dr. Richard Pazdur: The U.S. Food and Drug Administration (FDA) is providing this communication to increase ...

Today, the Advisory Committee on Immunization Practices (ACIP) voted to end its recommendation of the universal birth dose of the Hepatitis B (HepB) vaccine and instead recommend the birth dose only f ...

ASCO has been notified about a recent safety update relating to the drug COPIKTRA TM (duvelisib) under the Food and Drug Administration’s (FDA) Risk Evaluation and Mitigation Strategy (REMS) program.